1. 1199: CEFTOLOZANE-TAZOBACTAM PHARMACOKINETICS IN A PATIENT ON CONTINUOUS VENO-VENOUS HEMOFILTRATION. Issue 12 (December 2015) Authors: Oliver, Wesley; Gonzales, Jeffrey; Heil, Emily; Mehrotra, Shailly; Robinett, Kathryn; Saleeb, Paul; Nicolau, David Journal: Critical care medicine Issue: Volume 43:Issue 12(2015)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Extrapolation of Efficacy from Adults to Pediatric Patients of Drugs for Treatment of Partial Onset Seizures: A Regulatory Perspective. Issue 4 (3rd July 2022) Authors: Mehrotra, Shailly; Bhattaram, Atul; Krudys, Kevin; Bewernitz, Michael; Uppoor, Ramana; Mehta, Mehul; Liu, Tao; Sheridan, Philip; Hershkowitz, Norman; Kozauer, Nicholas; Bastings, Eric; Dunn, Billy; Men, Angela Yuxin Journal: Clinical pharmacology & therapeutics Issue: Volume 112:Issue 4(2022) Page Start: 853 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Neurotransmitter transporter occupancy following administration of centanafadine sustained-release tablets: A phase 1 study in healthy male adults. (February 2023) Authors: Matuskey, David; Gallezot, Jean-Dominique; Nabulsi, Nabeel; Henry, Shannan; Torres, Kristen; Dias, Mark; Angarita, Gustavo A; Huang, Yiyun; Shoaf, Susan E; Carson, Richard E; Mehrotra, Shailly Journal: Journal of psychopharmacology Issue: Volume 37:Number 2(2023) Page Start: 164 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Parent‐Metabolite Pharmacokinetic Modeling and Pharmacodynamics of Veliparib (ABT‐888), a PARP Inhibitor, in Patients With BRCA 1/2–Mutated Cancer or PARP‐Sensitive Tumor Types. (7th April 2017) Authors: Niu, Jing; Scheuerell, Christie; Mehrotra, Shailly; Karan, Sharon; Puhalla, Shannon; Kiesel, Brian F.; Ji, Jiuping; Chu, Edward; Gopalakrishnan, Mathangi; Ivaturi, Vijay; Gobburu, Jogarao; Beumer, Jan H. Journal: Journal of clinical pharmacology Issue: Volume 57:Number 8(2017) Page Start: 977 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Personalized Management of Chemotherapy‐Induced Peripheral Neuropathy Based on a Patient Reported Outcome: CALGB 40502 (Alliance). (4th December 2019) Authors: Sharma, Manish R.; Mehrotra, Shailly; Gray, Elizabeth; Wu, Kehua; Barry, William T.; Hudis, Clifford; Winer, Eric P.; Lyss, Alan P.; Toppmeyer, Deborah L.; Moreno‐Aspitia, Alvaro; Lad, Thomas E.; Velasco, Mario; Overmoyer, Beth; Rugo, Hope S.; Ratain, Mark J.; Gobburu, Jogarao V. Journal: Journal of clinical pharmacology Issue: Volume 60:Number 4(2020) Page Start: 444 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Pharmacometrics‐guided drug development of antihyperhidrosis agents. (18th June 2015) Authors: Mehrotra, Shailly; Schmith, Virginia D.; Dumitrescu, Teodora Pene; Gobburu, Jogarao Journal: Journal of clinical pharmacology Issue: Volume 55:Number 11(2015:Nov.) Page Start: 1256 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Population pharmacokinetics and site of action exposures of veliparib with topotecan plus carboplatin in patients with haematological malignancies. (19th March 2017) Authors: Mehrotra, Shailly; Gopalakrishnan, Mathangi; Gobburu, Jogarao; Greer, Jacqueline M.; Piekarz, Richard; Karp, Judith E.; Pratz, Keith; Rudek, Michelle A. Journal: British journal of clinical pharmacology Issue: Volume 83:Number 8(2017) Page Start: 1688 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗